IFNA1 and HIV infectious disease: The current study examines plasma from people without HIV infection and with a low risk of HIV exposure for antibody capable of promoting HIV-induced IFN-α production to a degree that could explain how an otherwise, slow initially weak and virus-compromised IFN-α response could terminate HIV infection.